Company Level Brands Inc Nyse

Company Level Brands Inc Nyse

US52730Q2093

Equities

US52730Q2093

Pharmaceuticals

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sector Other Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sector Other Pharmaceuticals

Inactive Instrument

cbdMD, Inc. produces and distributes cannabidiol (CBD) products. The Company owns and operates CBD brands cbdMD, Paw CBD and cbdMD Botanicals. Its cbdMD brand of products includes a range of premium every day and functional CBD products, including tinctures; gummies; topicals; capsules; drink mixes; and sleep, focus and calming aids.Its Paw CBD brand of products includes a line of veterinarian-formulated products including tinctures, chews, topicals products in varying strengths and formulas. Its cbdMD Botanicals brand of beauty and skincare products features facial oil and serum, toners, moisturizers, clear skin, facial masks, exfoliants and body care stock-keeping units (SKU). cbdMD, Paw CBD and cbdMD Botanicals products are distributed through its e-commerce websites, third party ecommerce sites, select distributors and marketing partners as well as a variety of brick-and-mortar retailers. Its products are sold through www.cbdmd.com, www.pawcbd.com, and cbdmdbotanicals.com Websites.

USD in Million	2022	Weight	2023	Weight	Delta
E-Commerce 80.5 %	26	74.7 %	19	80.5 %	-26.48%
Wholesale 19.5 %	9	25.3 %	5	19.5 %	-47.38%

USD in Million	2022	Weight	2023	Weight	Delta
United States 100.0 %	35	100.0 %	24	100.0 %	-31.77%

Managers	Title	Age	Since
T. Kennedy CEO	Chief Executive Officer	45	30/09/20
Zeb Booker CTO	Chief Tech/Sci/R&D Officer	-	31/12/18
Sibyl Swift CTO	Chief Tech/Sci/R&D Officer	43	28/04/21
Shannon Charles SAM	Sales & Marketing	-	31/12/22
Dave Johnson PRN	Corporate Officer/Principal	-	30/11/21
Brad Trawick PRN	Corporate Officer/Principal	-	21/07/21
Francisco Mangual SAM	Sales & Marketing	-	31/10/18
Lance Blundell LAW	General Counsel	52	31/12/17

Members of the board	Title	Age	Since
Bakari Sellers BRD	Director/Board Member	39	28/02/17
Scott Stephen CHM	Chairman	58	18/04/19
William Raines BRD	Director/Board Member	64	18/04/19
Sibyl Swift CTO	Chief Tech/Sci/R&D Officer	43	28/04/21

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	3,869,082	3,223,849 ( 83.32 %)	0	83.32 %
Stock B	0	5,000,000	0	0

Name	Equities	%	Valuation
Raymond Coffman 10.02 %	387,695	10.02 %	257 429 $
Crc Investment Fund LP 3.621 %	140,114	3.621 %	93 036 $
Worldwide Media Services Group, Inc. 3.481 %	134,679	3.481 %	89 427 $
Renaissance Technologies LLC 0.9307 %	36,011	0.9307 %	23 911 $
Virtu Financial LLC 0.5154 %	19,940	0.5154 %	13 240 $
Vanguard Group, Inc. (Subfiler) 0.3371 %	13,042	0.3371 %	8 660 $
BlackRock Institutional Trust Co. NA 0.3013 %	11,658	0.3013 %	7 741 $
Geode Capital Management LLC 0.2977 %	11,520	0.2977 %	7 649 $
Scott Stephen 0.2620 %	10,138	0.2620 %	6 732 $
Bakari Sellers 0.2439 %	9,438	0.2439 %	6 267 $

Name	Equities	%	Valuation
Chapin Davis, Inc. 1.600 %	80,000	1.600 %	54 320 $
CSS LLC 1.488 %	74,398	1.488 %	50 516 $
UBS Securities LLC 0.3507 %	17,536	0.3507 %	11 907 $
Commonwealth Equity Services LLC 0.2000 %	10,000	0.2000 %	6 790 $
Morgan Stanley Smith Barney LLC 0.0155 %	774	0.0155 %	526 $

cbdMD, Inc.

8845 Red Oak Boulevard

28217, Charlotte

http://www.cbdmd.com

	1st Jan change	Capi.
NOVO NORDISK A/S	+41.96%	630B
JOHNSON & JOHNSON	-7.15%	350B
MERCK & CO., INC.	+18.77%	328B
ABBVIE INC.	+8.79%	298B
ASTRAZENECA PLC	+18.02%	246B
ROCHE HOLDING AG	+1.27%	225B
NOVARTIS AG	+11.95%	218B
AMGEN INC.	+3.68%	160B
PFIZER, INC.	-4.38%	156B

Other Pharmaceuticals

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals